semaglutide cardiovascular outcomes trial SELECT flow trial semaglutide all-cause mortality

I found out it primarily acts on the brain, particularly in areas like the hypothalamus, which is basically our body's control center for hunger and satiety

Alex Cook: In this study, we saw that after two years, those taking a GLP-1 drug for obesity and without diabetes, experienced an average of $4,206 higher cost of care in their second year compared to like members not taking a GLP-1 drug for obesity

Wang ZY, Liu YY, Liu GH, Lu HB, Mao CY (2018) L-carnitine and heart disease

Maintenance Doses and Long-Term Health Improvements One of the most important questions when using weight loss medications is how to keep the weight off once youve reached your goal

Daily Microdosing: Some users take one-seventh of the weekly dose each day

Sall C, Alifrangis L, Dahl K, Friedrichsen MH, Nygard SB, Kristensen K